Valuation: Kwality Pharmaceuticals Limited

Market Cap 38.28B 403M 362M 334M 303M 566M 573M 4B 1.59B 20.07B 1.51B 1.48B 63.63B P/E 2025
22.6x
P/E 2026 20.1x
Enterprise Value 39.55B 416M 374M 345M 313M 585M 592M 4.14B 1.64B 20.73B 1.56B 1.53B 65.74B EV / Sales 2025
2.7x
EV / Sales 2026 2.95x
Free-Float
22.51%
Yield 2025 *
-
Yield 2026 -
09-21 Kwality Pharmaceuticals Limited(BSE:539997) added to S&P Global BMI Index CI
09-02 Kwality Pharmaceuticals Limited Appoints Swanith Kapoor, as the Non-Executive Independent Director, Effective 02 June, 2026 CI
08-10 Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
06-02 Kwality Pharmaceuticals Limited Announces Resignation of Kartik Kapur as Independent Director, Effective June 02, 2026 CI
05-19 Kwality Pharmaceuticals' Consolidated Profit Rises in Fiscal Q4; Shares Jump 9% MT
05-19 Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027 CI
05-19 Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
03-11 Chatha Foods Limited Announces Change in Designation of Mrs. Rachna Singh Chaudhary as Chief Human Resource Officer, Effective March 11, 2026 CI
03-10 Kwality Pharmaceuticals completes phase 1 BE studies for three molecules RE
02-12 Kwality Pharmaceuticals' Consolidated Profit Jumps in Fiscal Q3; Shares Surge 16% MT
02-12 Kwality Pharmaceuticals Ltd Dec-quarter consol net profit 160.1 million rupees RE
02-12 Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02-02 Kwality Pharmaceuticals Limited Announces Completion of Term of Pankaj Takkar and Ravi Shanker as Independent Directors and from Committees Membership and Chairmanship, Effective January 31, 2026 CI
1 day+2.30%
1 week+7.46%
Current month+1.46%
1 month+3.04%
3 months+42.48%
6 months+128.86%
Current year+232.86%
1 week 3,374.9
Extreme 3374.9
3,706
1 month 3,227
Extreme 3227
3,780.2
Current year 1,020
Extreme 1020
3,866.55
1 year 828.8
Extreme 828.8
3,866.55
3 years 320
Extreme 320
3,866.55
5 years 248
Extreme 248
3,866.55
10 years 21.3
Extreme 21.3
3,866.55
Manager TitleAgeSince
Chief Executive Officer 72 04/05/1983
Director of Finance/CFO 32 22/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 72 04/05/1983
Director/Board Member 58 01/08/1995
Director/Board Member 64 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
+2.30%+7.46%+306.26%+1,019.82% 394M
+0.65%+1.82%+57.77%+128.72% 1,143B
+0.20%+4.79%+44.51%+83.73% 647B
+0.13%+0.65%+25.98%+102.02% 506B
+0.09%+2.02%+53.16%+65.73% 384B
-0.27%-5.51%+62.73%+37.93% 350B
+1.07%+2.82%+31.95%+54.15% 293B
+0.38%+2.17%+3.89%+26.13% 265B
+0.94%+3.05%+54.65%+71.63% 242B
+0.74%+4.25%+35.82%+105.86% 197B
Average +0.62%+1.51%+67.67%+169.57% 402.79B
Weighted average by Cap. +0.40%+0.71%+44.98%+87.60%

Financials

2025 2026
Net sales 3.7B 38.97M 34.98M 32.3M 29.29M 54.74M 55.41M 387M 154M 1.94B 146M 143M 6.15B 5.03B 52.96M 47.54M 43.89M 39.8M 74.39M 75.3M 526M 209M 2.64B 199M 195M 8.36B
Net income 398M 4.19M 3.76M 3.48M 3.15M 5.89M 5.96M 41.68M 16.55M 209M 15.75M 15.41M 662M 673M 7.09M 6.36M 5.88M 5.33M 9.96M 10.08M 70.45M 27.98M 353M 26.61M 26.05M 1.12B
Net Debt 977M 10.28M 9.23M 8.52M 7.73M 14.45M 14.62M 102M 40.58M 512M 38.61M 37.78M 1.62B 1.27B 13.38M 12.01M 11.09M 10.06M 18.8M 19.03M 133M 52.81M 666M 50.23M 49.16M 2.11B
Projected Income Statement - Annual - Kwality Pharmaceuticals Limited
Logo Kwality Pharmaceuticals Limited
Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.
Employees
1,137
Date Price Change Volume
28/10/26 ₹3,689.25 +2.30% 4,812
27/10/26 ₹3,606.40 +4.41% 1,856
26/10/26 ₹3,453.95 -2.20% 7,387
23/10/26 ₹3,531.70 -2.48% 11,121
22/10/26 ₹3,621.45 +5.49% 8,838

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Kwality Pharmaceuticals Limited